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ETHICS CENTER 
BIOETHICS 
CONFERENCE 
SLATED 
FOR APRIL 
ROBERT VEATCH TO LECTURE 
IN JANUARY AT LOMA LINDA 
"Biomedical Ethics Today: Old 
Models and New," a conference for 
physicians, nurses, ministers and 
other interested persons, will be 
held at Loma Linda University April 
21-22, 1985. The LLU Center for 
Christian Bioethics and the Institute 
for Society, Ethics and the Life 
Sciences of Hastings-on-the-Hud-
son, New York, will collaborate in 
the presentations. 
A discussion of ethical issues in 
organ transplantation, presented by 
Arthur Caplan, Ph.D., Associate for 
the Humanities at the Hastings 
Center, will be one of the confer-
ence's special features. This lecture, 
(continued on page 2) 
Robert M. Veatch, Professor of 
Medical Ethics, Kennedy Institute 
of Ethics, Georgetown University, 
and a noted author will deliver the 
inaugural address of the Medicine 
and Society Conferences, a series 
of monthly meetings sponsored by 
the Center for Christian Bioethics 
and Loma Linda University School 
of Medicine. Veatch's topic is 
"Human Experimentation: The Pro-
cess of Ethical Decision-making." 
The Veatch lecture will be held 
January 16, 1985, from 12 noon to 
1 :00 p.m. in the Lobby Level Amphi-
theater of LLUMC. Subsequent con-
ferences will be held on the second 
Wednesday of the month. 
Jack Provonsha, Directo'r of the 
Ethics Center, will formally respond 
to Veatch's lecture. 
Although the first conference will 
be a lecture, normally the format 
will include brief statements by an 
interdisciplinary panel of profes-
CHARLES TEEL JR. WILL LEAD 
CENTRAL AMERICA PROBE 
Students in "Biblical Ethics in the 
Modern World," a new undergradu-
ate course, along with students in 
the Honors Program of Loma Linda 
University's College of Arts and 
Sciences, will have an opportu~ity 
to explore the relationsh ips between 
Biblical ethics, Christian ethics, and 
social change during a tour of 
Mexico and Central America led by 
Charles Teel, Jr., Chairman of the 
Department of Christian Ethics. 
During both the upcoming Christ-
mas vacation and the 1985 Spring 
vacation, students in these classes 
will interview leaders in Mexico 
from groups as diverse as the 
Maryknoll Order and the Campus 
Crusade for Christ. Those who will 
be interviewed include a mother 
rearing four children in a "squatters 
settlement" in Cuernavaca, a co-
founder of Christians for Socialism, 
an evangelist with Campus Crusade 
for Christ, a professor at a Baptist 
theological seminary, the Roman 
Catholic Bishop of Cuernavaca, 
and a leader of a "base Christian 
community." 
On November 18, Professor Teel, 
a sociologist and ethicist who has 
led study tours for several years, 
presented the 1984 Lewis Lecture 
(continued on page 8) 
sionals followed by an open discus-
sion. Members of the panel will 
typically include a physician, an 
ethicist or theologian and a member 
of such professions as law, social 
work, public health or hospital ad-
ministration, depending on the dis-
cussion topic. 
The conference, open to all inter-
ested persons, wi II be a resou rce for 
health care professionals from 
LLUMC and the Inland Empire. 
Prior to each meeting, information 
fliers will be sent to hospitals, 
agencies and interested persons in 
the area. 
Funding for the first year of con-
ferences has been provided by the 
Wuchenich Foundation. The budget 
for the first year, in excess of 
$7,500, covers honoraria and travel 
for speakers and panelists, pub-
licity, and bibliographic material for 
each session. The budget also pro-
vides for videotaping the confer-
ences for instructional use by the 
University. The tapes will also be 
made available to individuals and 
institutions at a nominal charge. 
The monthly conferences are 
administered by a subcommittee of 
the Ethics Center Board of Coun-
cilors. Members of that committee 
are LLU Faculty: David Larson, 
Associate Professor of Christian 
Ethics; Gordon Thompson, Asso-
ciate Professor of Medicine; and R. 
Bruce Wilcox, Professor of Bio-
chemistry. The committee is chaired 
by James Walters, Assistant Pro-
fessor of Christian Ethics. 
The January 16 session is the first 
in a cluster of three conferences 
dealing with the appropriate use of 
new medical technologies. The topic 
of the second conference is cross-
species transplantation. The third 
conference will deal with the alloca-
tion of scarce medical resources. 
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CONFERENCE (continued) 
scheduled for Sunday, April 21, at 
7:30 p.m. will be open to the public. 
Other speakers are Daniel Cal-
lahan and Ronald Sayer of the 
Hastings Center, and Jack Pro-
vonsha, David Larson, James WaI-
ters and Charles Teel, Jr., of the 
LLU Ethics Center. They will explore 
ethical issues surrounding birth and 
death, allocation of health care, 
ethics of experimenting upon living 
beings, and other topics. 
The conference will consist of 
seven gO-minute sessions. Each 
session will begin with a 3D-minute 
lecture by one of the ethicists, and 
two 12-minute responses by com-
mentators will follow. A moderator 
will then lead a ' discussion with 
opportunity for audience participa-
tion. The first session will begin 
Sunday morning, April 21, and the 
conference will conclude with three 
meetings on Monday, April 22. 
Commentators and moderators 
are being chosen for their expertise 
in the topics covered. Each of the 
three speakers of the Hastings Cen-
ter will comment on another speak-
er's presentation. The other com-
mentators and moderators will be 
chosen from academic and medical 
institutions in Southern California. 
Although the conference will deal 
with biomedical issues, many non-
medical persons will be interested 
in these socially important topics. 
·AII are welcome. The conference 
will have national advertising, al-
though medical professionals in the 
West will be the target audience. 
For more information about the 
conference and for registration 
materials, please fill out the re-
sponse form in this newsletter and 
mail it the the Ethics Center. 
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REFLECTIONS 
. REGARDING BABY FAE . 
ETHICAL ISSUES EVOKED BY BABY FAE 
James w. Walters 
Baby Fae survived four times longer than any 
newborn with any type of heart transplant. The historic 
nature of this feat is settled, but its value variously is 
deemed success or failure. Such controversy is more 
good than bad. We'd be in trouble if a baboon heart 
transplant caused nary a social ripple. Debate, 
discussion and eventual consensus is indispensable if 
society is to remain intact as it encounters the totally 
new. 
This transplant was clearly a scientific marvel, but 
some societal issues raised remain opaque. Time and 
effort are required for millions of c.itizens to process the 
unusual - even the beneficially unusual. Not out of 
callousness to the value of Baby Fae's extended life, 
but because of our profound regard for all human life, 
must we grapple with basic ethical questions which 
emerge from, but are not limited to, the recent baboon 
heart transplant. Hard questions must be asked of all 
bold new procedures in human treatment. I will 
develop one question evoked by Baby Fae's experience 
and mention three others. 
1. Does the experimental nature of a procedure 
override its therapeutic intent? Most of us don't flinch 
at using white mice as "experimental animals", but 
human beings never! Of course, humans share the 
mortal nature of all animals, but of tremendous 
importance is the way we die. A quick natural death is 
morally preferable to an artificially prolonged suffering 
death - even if many others stand to benefit. To exploit 
innocent individuals for the good of others is morally 
suspect. Therefore, participation of human subjects in 
original procedures presupposes ajustifiable likelihood 
"The Medical Center commendably exceed-
ed the federal government's minimal re-
quirements by having the IRB examine this 
privately-funded research." 
of personal therapeutic "benefit" - albeit a word of 
new meaning in the context of fatal disease. For good 
reason medical researchers often utilize thousands of 
sub-human subjects to perfect a therapy before 
applying it to human beings. 
In the case of Baby Fae, the Loma Linda University 
Medical Center's I nstitutional Review Board reasoned 
that the benefit to the infant was worth the risk. The 
Medical Center commendably exceeded the federal 
government's minimal requirements by having the IRB 
examine this privately-funded research. However, the 
thoroughness of that decision-making process is yet to 
be fully elaborated. More light will dispell the darkness 
in the public media on which some experts - medical 
and ethical - have based negative conclusions. The 
criticism of unjustified experimentalism may simply 
evaporate when the scientific facts and ethical 
procedures are better known. 
Other major adv~nces in heart transplantation have 
been preceded by considerable published scientific 
literature and public discussion. The discussion leading 
to human heart transplants lasted over a decade. The 
determination and approval of the ethical protocol 
leading to Barney Clark's artificial heart transplant 
took 18 months. Although there is no formula for 
adequate prior or subsequent discussion, a presump-
tion toward open communication and broad consensus 
is ethically desirable. 
"Heart transplants for some babies pose 
profound questions when many other 
babies in our nation receive inadequate 
prenatal care and when still others starve to 
death in drought-stricken areas of the 
world." 
2. Is the consent of the parents truly informed? The 
rule of informed consent is difficult to apply in any 
case, but when "information" is non-existent due to the 
procedure's experimental nature the rule requires that 
utmost sensitivity be exercised. Parents with a 
terminally-ill newborn are extremely vulnerable and a 
third mile must be walked to protect their autonomy. 
Are the options for therapy, or lack thereof, presented 
in clear and unbiased language? Are the best possible 
predictions of quality-of-life told? Is every reasonable 
safeguard taken to guarantee an informed, objective 
environment of decision-making? To insure that 
Barney Cla,k's decision was uncoerced, a knowledge-
able "outside" physician was provided to the patient as 
his consultant and advocate. 
3. Is cross-species heart transplantation a wise use of 
limited medical resources? Because the cross-species 
heart transplantation is a costly "rescue" measure 
rather than a preventive technique, some instinctively 
question its appropriateness. Although morbidity and 
mortality rates were drastically reduced by public 
health measures, we should not conclude that society 
should invest all its medical dollars in prevention. A just 
allocation of the medical dollar will proportionally 
address the needs of all , both prevention and therapy. 
A basic fact illumines the Baby Fae case: the actual 
cost of the baboon heart transplant was relatively 
low. Although some new drugs cost hundreds of 
millions of dollars for research and development, 
and although the National I nstitutes for Health 
expended $180 million dollars developing its artificial 
(continued on page 6) 3 
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THE BEST AVAILABLE THERAPY 
Jack W. Provonsha 
One of the goals of medical research is to discover 
tolerable, practical alternatives to untimely death -
tolerable, because there are worse conditions than 
death (medicine is concerned not only with the 
quantity, but with the quality of life) - practical, 
because while theoretically possible some alternatives 
may not in fact be available. The investigation that 
preceded it and the actual transplantation of a seven-
month old baboon heart into Baby Fae's chest on 
October 26 were carried out with this larger purpose in 
mind and it is important to remember this when 
reviewing the controversial Baby Fae case. 
Organ replacement, either by the transplant of 
organs from donor sources or by mechanical devices is 
an example of attempts to achieve.this therapeutic 
goal. Unfortunately, for the transplant of organs there 
are not, and probably will never be, enough human 
donors available to supply the need. This is especially 
true for the neonate because of special difficulties 
peculiar to that period of life. For one thing, neonates 
are rarely involved in the death by accident or violence 
that constitutes the primary source of donor organs for 
older members of the population. Finding a newborn 
who has suffered brain-death but posseses a healthy 
heart undamaged by the circumstances often asso-
ciated with neonatal brain-death, and is of the right size 
and tissue type, and in the right geographic location so 
that transport time does not compromise the organ, 
and for whom proxy donor consent has properly been 
given, present a complex of difficulties (further 
compounded if the recipient is already moribund) that 
render availability unlikely. Add to this the difficulty 
experienced in diagnosing isolated brain-death in the 
newborn, and one comes to see the practical limits of 
the allograft alternative for newborns. If an allograft 
were found it would seem an extraordinary coincidence 
almost guaranteeing that tissue-type selection would 
be limited. Cardiac allografts do not at present appear 
to provide the practical alternative to the untimely 
death we seek. Practical mechanical hearts still remain 
a distant vision and no one that I know of is preparing 
one for neonates. 
Two other alternatives must therefore be considered. 
One of these is the Norwood procedure - a several 
stage surgical effort to rearrange the structures of the 
hypoplastic left heart so as to permit the right ventrical 
"There are worse conditions than death." 
to carry the load of the missing left. The procedure is 
still highly experimental with a prohibitive mortality 
rate and of dubious long range outcome - including a 
questionable quality of life. A successful surgical result 
provides somewhat greater longevity, but with a 
critically limited heart for the remainder of the child's 
life. 
The only other present alternative is the xenograft 
route taken by Dr. Leonard Bailey at Loma Linda. The 
practicality of this approach derives from the fact that 
donor organs are readily available, that is if one uses 
baboons (most of the other larger primates are 
protected species). There are other advantages. One 
does not have to wait for brain-death to occur before 
harvesting baboon hearts. This virtually guarantees 
healthy, functional donor organs. The proper size can 
easily be selected and one has some control over time 
factors both for donor transport and adequate tissue 
testing. 
The main practical drawback is, of course, xenograft 
rejection and here the precedents are not encouraging, 
to say the least. A fair number of xenograft transplants 
have been attempted in the past with dismal results in 
every instance. 
There are some interesting innovations in the case of 
Baby Fae, however, raising the possibility of a different 
outcome. First, the immunological investigation of 
potential animal donors has proceded far beyond 
anything done previously. Dr. Bailey and his associates 
have been studying xenograft techniques on animal 
models, chiefly sheep and goats - with varying 
degrees of success and with the accumulation of a 
large body of experimental data. The team's work 
"As much experimental preparation had 
been made as possible using animal 
models." 
included extensive tissue typing studies in baboons 
and included the profusion of a baboon heart with 
human blood - incidentally without apparent evidence 
of rejection. 
·What remained was the xenograft to a human host. In 
looking for a human model, the hypoplastic left heart 
syndrome was chosen because it was within Dr. 
Bailey's competence as a pediatric thorasic surgeon 
and because the condition untreated was uniformly 
lethal. Success would, of course, have much broader 
implications. Satisfaction of the criteria noted at the 
beginning seemed assured. The animal studies 
indicated that the procedure was well-tolerated. As 
confirmation, Baby Fae's condition post-op was 
obviously not an intolerable one. We have noted its 
practicality above. 
One of the startling results of this research was the 
finding of a much greater histo-comparability (the key 
figures seem to prefer this term to histo-compatabirity) 
between humans and at least some baboons than had 
previously been expected. Moreover, never had an 
attempt been made on so young a patient with the 
possible benefit of an immature immunological system 
and its diminished tendency to reject. 
Another difference was cyclosporine-A, a newer 
immunosuppressive drug that has made a great deal of 
difference to transplant technology. These three factors 
constituted a basis for hope that this alternative might 
offer a reasonable possibility of success - even a 
greater possibility than any of the other options 
including the human allograft - in the rare instance 
that one were really available. (A human source is 
obviously no guarantee against rejection. Allografts 
are also rejected.) The other alternative was certain 
death and Baby Fae came close to selecting it more 
than once prior to surgery. . 
What we have had then, in the Baby Fae case, was a 
slightly premature child facing certain death unless 
( 
something drastic were done to correct her congenital 
heart defect. There were four options, all but the first 
highly experimental and none of them good. (1) Death, 
(2) the Norwood procedure, (3) a human allograft, and 
(4) a baboon xenograft. The ethical requirement that 
the incompetent patient's well-being take priority over 
"5 he apparently died the death of an 
allograft rejection rather than that of a 
xenograft." 
purely experimental purposes demanded that the best 
available option be selected even if this interfered 
temporarily with experimental goals. 
Option (1) death, was unacceptable by all of the 
tenents of medicine, providing a reasonable quality of 
life was a possibility. (2) The Norwood procedure had 
serious problems including an unacceptably high 
mortality rate and a reduced quality of life. (3) A human 
allograft was impractical as a solution to the larger 
organ transplant problem and presented specific 
insurmountable difficulties for the newborn which 
leaves us with (4), the baboon xenograft. In this case, 
because of newer information and better immuno-
suppressant drugs, while there remain large questions, 
there was provided a real measure of hope. If it were 
successful, it would not only offer a practical solution 
to the Baby Faes among us but a host of other 
possibilities down the line. On balance, (4), as 
questionable as it was, offered at least as great, and 
possibly greater therapeutic hope than either (2) or (3). 
We would not know if the xenograft were not attempted. 
As much experimental preparation had been made 
as possible using animal models. Proper consent was 
apparently provided including the protection of the 
incompetent. Therapeutic goals were sought rather 
than purely experimental ones; that is, that the baby 
was considered to be more important than the 
experiment. 
Baby Fae lived almost 3 weeks after surgery, 
apparently at least two good weeks. This was much 
longer than any other xenograft had ever survived. And 
when she died she apparently died the death of an 
allograft rejection rather than that of a xenograft. An 
enormous amount of information has been accumu-
lated that may augur well for the future. Was it worth it? 
Only the future will tell us for sure. But at least it seems 
that those involved have acted with ethical responsi-
bility in the past and the present. 
Jack W. Provonsha, a minister, physician, and teacher with degrees from 
Pacific Union College, Lorna Linda University, Harvard University, and 
Claremont Graduate School, is the first Director of the Center for Christian 
Bioethics. He serves as Professor of Philosophy of Religion and Christian 
Ethics at Lorna Linda as well. Professor Provonsha and his wife Margaret, 
also a physician, divide their time between their home in Yucaipa, 
California and their "hideaway" near the Puget Sound. 
THE MORALITY OF EXPERIMENTING 
UPON CHILDREN 
David R. Larson 
At least three views prevail today regarding the 
morality of performing medical experiments upon 
children. Each view possesses a distinCtive intellectual 
history. Each view includes its own assumptions and 
implications. And each view provides a vantage point 
from which to survey the deci~ion to transplant a 
"Research can be morally right, utilitarians 
argue, if the good it produces for the 
community outweighs the evil it entails." 
baboon's heart into Baby Fae. 
The utilitarian view is probably the most permissive. 
It holds that a medical experiment can be justified 
ethically if it promises to benefit society in the long run. 
Utilitarians, the modern followers of Jeremy Bentham 
(1748-1832) and John Stuart ~ Mili (1806-1873), are 
directly concerned about the "common good." They 
are indirectly concerned about protecting individuals 
to the degree that such efforts benefit society. Even if 
the one upon whom an experiment is performed is a 
child, and even if the study is not designed to benefit 
that particular youngster, the research can be morally 
right, utilitarians argue, if the good it produces for the 
community outweighs the evil it entails. 
Utilitarians will disagree with each other regarding 
the social value of Baby Fae's surgery. Some will 
applaud it as an attempt to develop a steady source of 
inexpensive and healthy organs. Others will criticize it 
for spending so much to solve a rare malady when 
there are cheaper ways to improve the public's health. 
And utilitarians will advance other arguments both pro 
and con. But all utilitarians will be primarily concerned 
about the impact of such experiments upon the total 
well-being of society. 
The Kantian view is probably the most restrictive. 
Princeton University's Paul Ramsey, a contemporary 
thinker who is informed by I mmanuel Kant's (1724-
1804) insistence that a person should never be treated 
as a mere means to something else, holds that it is 
morally right to perform a medical experiment upon a 
child if and only if the researchers intend to help that 
particular boy or girl. Ramsey believes that a child 
cannot give competent, free, and informed consent for 
an experiment that is designed to benefit others, and 
that no one else, not even the child's parent or legal 
"Kantian moralists will be primarily con-
cerned about protecting children against 
experimentation from which they cannot 
benefit." 
guardian, is morally authorized to approve such 
"treatment." He refers to the practice of performing 
nontherapeutic experiments upon children, with or 
without parental consent, as a "sanitized form of 
barbarism." (continued on page 6) 5 
6 
continued 
Kantian thinkers will debate the therapeutic nature of 
Baby Fae's surgery. No responsible person will doubt 
that Doctor Bailey and his team intended to help their 
dying patient by replacing her heart with that of a 
baboon. But some will wonder if in November of 1984 
there was enough favorable evidence to make this 
attempt at cross-species transplantation a prudent 
gamble. Others will wonder how promising the odds 
must be before an experiment can be called "thera-
peutic" when it is certain that the patient will die and 
when the only other medical options are virtually 
palliative. Still others will doubt that ethicists have the 
right to tell others what odds they may accept for their 
children, or that they have the professional competence 
to pass judgment upon the scientific feasibility of a 
therapeutic venture. I n any case, Kantian moralists will 
be primarily concerned about protecting children 
against experimentation from which they cannot 
benefit. . 
It is not as though only utilitarians are interested in 
social benefits and only Kantians are concerned about 
protecting individuals. But the relative importance 
"McCormick balances the protection of 
individuals and the betterment of society 
upon the validity of parental consent." 
placed upon either consideration does vary from group 
to group, as do the intellectual justifications for the 
conclusions that each group defends. 
The view of some thinkers who represent the natural 
law tradition initiated by Thomas Aquinas (1225-1274) 
and others is less permissive than the utilitarian view 
but also less restrictive than the Kantian view. Richard 
McCormick, for instance, believes that the consent of a 
parent or legal guardian may properly authorize a non-
therapeutic experiment upon a child providing certain 
provisions are met. These requirements stipulate that 
the parents choose with competence, knowledge, and 
freedom; that the experiment is designed so as to yield 
significant results; that the project cannot succeed 
without the use of children; and that the venture 
imposes no undue risk or discomfort upon the 
"I am more impressed by the arguments in 
favor of the surgery than I am by those 
against it, whether permissive, restrictive, 
or moderate." 
youngster. McCormick balances the protection of 
individuals and the betterment of society upon the 
validity of parental consent in carefully delineated 
circumstances. 
Those who take a moderate position something like 
McCormick's will be particularly interested in the 
process by which Baby Fae's parents gave their 
consent. Some will wish that the form they signed was 
longer and more technical. Others will argue for a brief 
and to-the-point document. Some will contend for a 
"patient's advocate." Others will insist that Baby Fae's 
parents were the best advocates she could have had. 
Some will contend that the details of the process and 
the consent form itself should be made public. Others 
will respect the desire to keep such things confidential. 
But the validity of parental consent will dominate the 
thinking of those who cannot condemn or condone the 
transplantation for either its social benefits or its 
therapeutic intentions alone. 
I am more impressed by the arguments in favor of the 
transplantation than I am by those against it, whether 
permissive, restrictive, or moderate. I think the 
surgery's social benefits outweighed its costs. I am 
persuaded that there was a clear intention to benefit 
Baby Fae and that her parents had a right to give her a 
chance despite the odds. And I am of the view that the 
consent process was adequate even though it can be 
refined. But more than anything else, I respect the 
courage, creativity, and compassion with which Doctor 
Bailey and his team struggled to save the life of one 
little girl. 
David R Larson is Associate Professor of Christian Ethics and Religion 
and Associate Director of the Center for Christian Bioethics at Loma Linda 
University. A graduate of Pacific Union College, the School of Theology at 
Claremont, and Claremont Graduate School, he lives near Lake Elsinore 
with his wife Judy, a commercial artist, their two sons and daughter. 
ISSUES EVOKED (continued from page 3) 
heart, LLU Medical Center expended less than two 
million dollars developing its cross-species heart 
transplant procedure. 
If Baby Fae-type operations become successful, 
their allocation and cost will be another question. Heart 
transplants for some babies pose profound questions 
when many babies in our nation receive inadequate 
prenatal care and sti II others starve to death in drought-
stricken areas of the world. 
4. Do baboons have a right to life? Yes. A moral 
argument can be made that all sentient animals, on an 
ascending scale, have a prima facie right to life. But is 
that the essential issue here? If the cross-species heart 
transplant has a reasonable chance for success, we 
cease to deal in animal/human abstractions and we 
begin weighing the life of a human newborn vs. the life 
of a young baboon. Most persons rightly favor the 
human infant. For those who do object to the sacrifice 
of baboons, there is a much more pressing issue: our 
society's mass, and often cruel, slaughter of millions of 
animals for our dinner tables. 
No facile answer will suffice. Do we really want large 
farms of high-level primates which we harvest for 
hearts and livers? If it were found that an endangered 
species of primates had the greatest immunological 
compatability with humans, what should we decide? 
The more general question for all medical research 
is not whether there should be medical progress -
even at the risk of possible human suffering. The issue 
is how that progress is made. Great ethical sensitivity is 
our only safeguard in preventing some future well-
meaning researcher from performing the ill-considered. 
Finally, I see two overriding issues in innovative 
human treatment: motivation and procedure. In this 
case, the dedicated perserverance of Doctor Bailey's 
team to the saving of Baby Fae's beautiful little life is a 
model of self-giving for medical science and an 
exemplar of humanness for us all. 
James W. Walters is Assistant Professor of Christian Ethics and Religion 
at Lama Linda University. He is also the chairman of the Ethics Center's 
Finance Committee. Professor Walters, who graduated from Southern 
College, Andrews University, and Clammont Graduate School served as a 
pastor in the southeastern and southwestern portions of this country 
before moving to Claremont where he now resides with his wife Priscilla, a 
physical therapist, and their two daughters. 
WHO SHOULD LIVE 
WHEN NOT ALL CAN? 
Triage and Justice by Gerald R. Winslow. Berkeley: 
University of California Press, 221 pp., bibliography, 
index. Reviewed by Brent T. Stanyer, graduate student, 
Lorna Linda University. 
The question "Who should live when not all can?" 
has been asked throughout medical history. The 
answers to that question have been as varied as the 
individuals involved. The process of al/ocating re-
sources in times of scarcity, called triage, is the subject 
of Triage and Justice by Gerald R. Winslow. 
Winslow begins by tracing the history of triage from 
its first use in the late eighteenth century to the present. 
Triage was first used in military medicine during the 
Napoleonic wars by Baron Dominique Larrey. During 
World War I it became an integral part of military 
medicine as the number of casualties exceeded the 
availability of treatment. The development of new 
medicines during World War " and new medical 
technologies in the postwar era led to the use of triage 
in civilian medicine, especially with hemodialysis for 
the treatment of end-stage renal disease. 
After examining these historical developments, 
Winslow develops two "prismatic cases" through 
which the principles of triage may be seen. First, 
planning for a San Francisco earthquake, and second, 
) allocation of the totally implantable artificial heart 
(TIAH). By examining medical decision-making during 
a hypothetical earthquake, the principles of triage may 
be applied to emergency medicine in a natural disaster. 
In the case of the artificial heart, the focus is on the 
allocation of a scarce new technology. 
Before presenting his own principle for triage, 
Winslow examines the utilitarian and egalitarian 
approaches to decision-making. Utilitarian approaches 
are concerned with the total amount of some good 
such as happiness or social worth. Egalitarian 
approaches, on the other hand, are concerned with 
equal access regardless of other factors. These two 
approa<.;hes have provided the basis for most of the 
triage decisions in the past. 
At this point Winslow outlines these approaches in 
light of the theory of justice of John Rawls. Rawls' basic 
position is that justice as fairness entitles all to an equal 
distribution of basic liberties. Inequities are also 
distributed equally, though Rawls does allow that 
inequities may be adjusted to reach the "greatest 
benefit for the least advantaged." (p. 116) Rawls' 
approach is basically an egalitarian one in which all 
would compete on an equal basis for any scarcities 
unless the scarcities were so dire as to rule out any 
possibility of a just distribution. 
Winslow adopts Rawls' theory of justice and applies 
it to the decision-making involved in triage. The 
"bottom-line" is fairness and impartiality for all. Re-
sources are allocated on a fair and equal basis through 
some method of random distribution to ensure that 
impartiality. However, the basic nature of providing 
medical care and the need for medical personnel and 
resources during emergency situations may warrant 
consideration of some utilitarian principles. For 
instance, the prinCiple of medical neediness is basic to 
the allocation of care. Therefore candidates for treat-
ment would have to pass the test of medical need. Also, 
the principle of immediate usefulness in a medical 
emergency might warrant the giving of priority to 
medical personnel so that they might provide care to 
others, But before these utilitarian principles may be 
considered it must be proven that they bear the burden 
of proof. 
Winslow clearly defines the issues involved with 
triage and applies the principles in a clear and 
consistent manner. He examines the assets and 
liabilities of both utilitarian and egalitarian principles, 
and although Winslow sides with the egalitarian 
principleof justice as fairness , he is no pure egalitarian . 
Various utilitarian principles supplement his approach . 
I would have liked, however, to have seen more 
attention given to approaches other than util itarianism 
and egalitarianism . The libertarian argument, for 
example, is very much a part of our free market 
economy and is held by a number of people. Though I 
do not agree with that argument, Winslow's treatise 
would have been more complete if approaches such as 
this one had also been considered. 
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John D. Ruffcorn, President of 
the Loma Linda University Medical 
Center, announced last summer 
that his institution will contribute 
$10,000.00 per year toward the 
operating expenses of the Center 
for Christian Bioethics "for the 
indefinite future." This commit-
ment, which approximates the 
annual yield from a $100,000.00 
endowment, was Mr. Ruffcorn'S 
response to requests made in behalf 
of the Ethics Center by Bruce 
Branson, Chairman of Loma Linda 
University's Department of Surgery, 
and V. Norskov Olsen, the Univer-
sity's former president. 
"This contribution is a gift that is 
making many other gifts possible," 
explained David Larson, the Ethics 
Center's Associate Director. "We 
are using the money from the Medi-
cal Center to contact individuals 
and groups who can contribute to 
the endowment. Without President 
Ruffcorn's support, our attempts to 
develop the endowment would have 
been stopped before they even 
started for lack of the money it takes 
to raise money." 7 
CAFFERKYS 
PROVIDE 
$100,000 
The Ethics Center will shortly 
receive $50,000 from Dr. and Mrs. 
Ronald Cafferky toward a $100,000 
special endowment. "This demon-
stration of confidence is most 
heartening," said Jack Provonsha, 
Center director. "It is this type of 
gift which assures the future of our 
fledgling ethics institute." 
The Ladd Endowment Fund, as 
the gift will be called, is made to 
Loma Linda University in honor of 
the parents of Anita Ladd Cafferky. 
Ervin E. Ladd graduated from LLU 
School of Medicine in 1948 and 
passed away in 1977. Margaret J . 
Ladd is now living in Lincoln City, 
Oregon. The gift is made in the 
name of the four Ladd children: E. 
David Ladd, R. Hudson Ladd, Anita 
Ladd Cafferky, and Nyra Thompson, 
married to Albert Thompson, M.D. 
"Our family deeply appreciated 
Dr. Provonsha's insight at a crucial 
time when my father was dealing 
with his terminal illness," Anita 
Cafferky explained. "Ideally, these 
life-and-death issues should be 
thought out in advance of the emer-
gency. However, so often that is not 
the case. It is important that some-
one of the caliber of Dr. Provonsha 
be available to give guidance. Our 
gift is intended to encourage ethical 
research and provide a helpful re-
source for others when it is needed." 
The Cafferky family, which in-
cludes four young children, resides 
in Claremont, California, where Ron 
Cafferky, also an alumnus of the 
LLU School of Medicine, practices 
psychiatry. 
The Ladd Endowment Fund will 
supplement the Center's basic 
endowment. "A robust endowment 
fu nd is vital so that the Center can 
rise above a precarious hand-to-
mouth existence and devote its 
energies to ethics," says James 
Walters, development committee 
chairperson. "We're all deeply 
grateful to the Cafferkys for their 
8 generosity." 
CENTER FOR CHRISTIAN BIOETHICS 
Division of Religion 
Lorna Linda University 
Lorna Linda, California 92350 
CENTRAL AMERICA PROBE 
(continued from page 1) 
for the College of Arts and Sciences 
entitled "Liberationists and Evangel-
ists: Logging a Passage through 
Mexico and Central America." Teel's 
other research interests include the 
life and thought of Martin Luther 
King, Jr., the social views of the 
Millerites in 19th century America, 
and the history of Seventh-day 
Adventist ethical thought. Doctor 
Teel, a graduate of Pacific Union 
College, Andrews University, Har-
vard Divinity School, and Boston 
University is an ordained Seventh-
day Adventist minister actively 
engaged in preparing materials for 
congregational worship. He teaches 
courses for pastors who lead wor-
ship as well. 
)-....." 
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ETHICS CENTER SEEKS $500,000 
A $500,000 endowment is the 
goal of the Ethics Center's campaign 
to secure its existence and provide 
financial stability. Gifts and com-
mitments total over $160,000 to 
date. "This is a significant begin-
ning," commented James Walters, 
chairperson of the development 
committee, "but we hope many will 
catch the vision of our potential and 
help assure the Ethics Center's 
future." One administrator of a large 
medical center suggested that the 
financial goal's decimal point was 
in the wrong place, that $5 million 
would be a more adequate goal, 
said Walters. 
A threefold effort in fund raising 
is underway, beginning with a letter 
campaign. Dr. Jack Provonsha, Dir-
ector of the Center and distin-
guished professor at Loma Linda 
University, has personally sent let-
ters to many of his former students. 
He also has sent letters to sub-
scribers of his Sabbath School 
tapes, with recordings of a meeting 
in which the Ethics Center was 
discussed. 
Secondly, meetings for persons 
interested in the Center have been 
held across the country. These 
persons were invited to a dinner 
which featured a lecture by Provon-
sha. Following the lecture, the finan-
cial needs of the Center were pre-
sented by one of Provonsha's col-
leagues: Charles Teel, Jr., David 
Larson, or James Walters. After the 
"nuts and bolts" of the Center were 
presented, individuals were invited 
to support the project. To dat' 
meetings have been held in Glen 
dale, Loma Linda; Palo Alto, San 
Diego, St. Helena, and Tustin, Cali-
fornia; Orlando, Florida; Hinsdale, 
Illinois; Kettering, Ohio; and Port-
land, Oregon. 
The third thrust of the campaign 
is to seek su pport from corporate 
entities and foundations . To date, 
corporate support has come from 
the Loma Linda University Medical 
Center in the form of a $10,000 per 
year commitment. Corporate sup-
port is also forthcoming from the 
Wuchenich Foundation. The Cali-
fornia Council forthe Humanities is 
considering a proposal for a $10,000 
grant to aid in the expenses of the 
upcoming "Biomedical Ethics To-
day" conference. 
The Center welcomes inquiries 
regarding future plans and long-
term needs. Write to Dr. Jack Pro-
vonsha, Director, The Ethics Center, 
LLU, Loma Linda, CA 92350. 
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